Skip to Content

ARA-290 10mg

For research use only. Not intended for human or animal consumption. These products are not approved by the FDA. By purchasing, you confirm that you are at least 21 years of age and a qualified researcher.

All peptide vials are supplied in lyophilized (powder) form and are not pre-reconstituted.

Description

ARA-290 (also known as Cibinetide, PHBSP, or pyroglutamate helix B surface peptide) is a synthetic undecapeptide (11 amino acids long) engineered as a non-erythropoietic analogue derived from the helix B surface region of erythropoietin (EPO), featuring an N-terminal pyroglutamic acid (Pyr or pGlu) residue for stability and a linear sequence without cyclic structures, disulfide bridges, or other post-translational modifications beyond the pyroglutamyl cyclization.

Its amino acid sequence is: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (or {Glp}-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser; single-letter code: pGlu-EQ L E R A L N S S, with free C-terminus).

Chemically, it has the molecular formula C₅₁H₈₄N₁₆O₂₁ and a molar mass of approximately 1257.3 g/mol (CAS 1208243-50-8). This oligopeptide is classified as a research chemical and is commonly utilized in laboratory investigations of peptide-receptor interactions

LEGAL DISCLAIMER!

All items available on this website are intended exclusively for research and development purposes, including laboratory and analytical applications, and are not meant for human or animal consumption in any form. The products are not designed to diagnose, treat, cure, or prevent any medical conditions, and their associated claims have not been reviewed or approved by the U.S. Food and Drug Administration. Mystical Mixtures operates solely as a supplier of research chemicals and is neither a compounding pharmacy nor an outsourcing facility as defined by sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act  

Description

GLP-2T is a synthetic dual incretin receptor agonist designed to target both GLP-1 and GIP receptors involved in metabolic and energy-balance signaling.

In vitro investigations commonly evaluate GLP-2T for its potential effects on:

  • Insulin and glucose regulation pathways

  • Appetite and satiety signaling

  • Energy metabolism and lipid utilization

  • Endocrine communication in metabolic research models

Due to its dual-receptor profile, GLP-2T is a widely studied compound in metabolic, obesity, and glycemic regulation research environments.

This material is supplied exclusively for controlled scientific experimentation.

Notes: 

  • Reconstitution Needed for Lyophilized Powder* Use a diluent such as Reconstitution Solution. NOT INCLUDED. MUST BE ORDERED SEPARATELY.